Sézary syndrome can be challenging to differentiate from erythrodermic inflammatory dermatitis. Biomarkers have been identified in Sézary syndrome, but have not been validated in multicenter studies in a cohort that allows comparisons. Boonk et al. now describe results that confirm the value of immunophenotype, and they report higher sensitivity and specificity for a set of genes used to distinguish Sézary syndrome from erythrodermic inflammatory dermatitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jid.2016.05.087 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!